FDA Inspection 1218338 — Roberto A. Pazo, MD
The FDA completed an inspection of Roberto A. Pazo, MD on Sep 8, 2023 in Zaragoza. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 8, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Zaragoza (Spain)
Additional details
Clinical Investigator (CI)